HST Global (HSTC) 10-Q 6 Nov 23 2023 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2023	Jul. 26, 2022
Details
Registrant CIK	0000797564
Fiscal Year End	--12-31
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Ex Transition Period	false
Entity Shell Company	false
Document Type	10-Q
Document Period End Date	Sep. 30, 2023
Entity File Number	000-15303
Entity Registrant Name	HST Global, Inc.
Entity Incorporation, State or Country Code	NV
Entity Tax Identification Number	73-1215433
Entity Address, Address Line One	150 Research Drive
Entity Address, City or Town	Hampton
Entity Address, State or Province	VA
Entity Address, Postal Zip Code	23666
City Area Code	757
Local Phone Number	766-6100
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		5,248,582
Amendment Flag	false
Document Fiscal Year Focus	2023
Document Fiscal Period Focus	Q3
Document Quarterly Report	true
Document Transition Report	false

Condensed Balance Sheets

Condensed Balance Sheets - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current Assets
Cash and cash equivalents	$ 2,000	$ 190
Total Current Assets	2,000	190
Total Assets	2,000	190
Current Liabilities
Accounts payable and accrued expenses	0	0
Accounts payable and accrued expenses - related parties	452,275	362,275
Loans or advances from related party	93,319	76,076
Accrued related party interest	11,574	7,696
Total Current Liabilities	557,168	446,047
Total Liabilities	557,168	446,047
Stockholders' Deficit
Preferred stock; 10,000,000 shares authorized, at $0.001 par value, 0 shares issued and outstanding at September 30, 2023 and December 31, 2022	0	0
Common stock; 200,000,000 shares authorized, at $0.001 par value, 5,248,582 shares issued and outstanding at September 30,2023 and December 31, 2022	5,248	5,248
Additional paid-in capital	5,417,236	5,417,236
Accumulated deficit	(5,977,652)	(5,868,341)
Total Stockholders' Deficit	(555,168)	(445,857)
Total Liabilities and Stockholders' Deficit	$ 2,000	$ 190

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Condensed Consolidated Statements of Operations
REVENUES	$ 0	$ 0	$ 0	$ 0
OPERATING EXPENSES
Consulting, related party	30,000	30,000	90,000	90,000
General and administrative	4,368	4,587	15,433	16,447
Total Operating Expenses	34,368	34,587	105,433	106,447
Loss from Operations	(34,368)	(34,587)	(105,433)	(106,447)
OTHER INCOME (EXPENSE)
Interest expense	1,362	1,049	3,878	2,916
Total Other Income (Expense)	(1,362)	(1,049)	(3,878)	(2,916)
Loss Before Income Taxes	(35,730)	(35,636)	(109,311)	(109,363)
Provision for Income Taxes	0	0	0	0
NET LOSS	$ (35,730)	$ (35,636)	$ (109,311)	$ (109,363)
Basic and Diluted Loss Per Share	$ (0.01)	$ (0.01)	$ (0.02)	$ (0.02)
Basic and Diluted Weighted Average Number of Common Shares Outstanding	5,248,582	5,248,582	5,248,582	5,248,582

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Stockholders' Deficit - USD ($)	3 Months Ended
	Sep. 30, 2023	Mar. 31, 2022	Sep. 30, 2022	Jun. 30, 2023	Jun. 30, 2022	Mar. 30, 2023
Common Stock
Balance, December 31, 2021	$ 5,248		$ 5,248
Net loss	0	$ 0	$ 0	$ 0	$ 0	$ 0
5,248,582			5,248
Balance, September 30, 2022	5,248		$ 5,248
Balance, December 31, 2022		5,248				5,248
Balance, September 30, 2023	5,248		5,248
Additional Paid-in Capital
Balance, December 31, 2021	5,417,236		5,417,236
Net loss	0	0	$ 0	0	0	0
5,248,582			5,417,236
Balance, September 30, 2022	5,417,236		$ 5,417,236
Balance, December 31, 2022		5,417,236				5,417,236
Balance, September 30, 2023	5,417,236		5,417,236
Retained Earnings
Balance, December 31, 2021	(5,977,652)		(5,832,630)
Net loss	(35,730)	(38,214)	$ (35,636)	(34,295)	(35,513)	(39,286)
5,248,582			(5,796,994)
Balance, September 30, 2022	(5,977,652)		$ (5,832,630)
Balance, December 31, 2022		(5,723,267)				(5,868,341)
Balance, September 30, 2023	(5,977,652)		(5,832,630)
Parent
Balance, December 31, 2021	(555,168)		(410,146)
Net loss	(35,730)	(38,214)	$ (35,636)	$ (34,295)	$ (35,513)	(39,286)
5,248,582			(374,510)
Balance, September 30, 2022	(555,168)		$ (410,146)
Balance, December 31, 2022		$ (300,783)				$ (445,857)
Balance, September 30, 2023	$ (555,168)		$ (410,146)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Cash Flows - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Operating Activities
Net loss	$ (109,311)	$ (109,363)
Changes in operating assets and liabilities
Accounts payable and accrued expenses	0	0
Accounts payable and accrued expenses-related parties	90,000	90,000
Accrued related party interest	3,878	2,916
Net Cash Used in Operating Activities	(15,433)	(16,447)
Investing Activities
Net Cash Used in Investing Activities	0	0
Financing Activities
Proceeds from loans or advances from related party	17,243	16,500
Net Cash Provided by Financing Activities	17,243	16,500
Net Change in Cash and Cash Equivalents	1,810	53
Cash and Cash Equivalents at Beginning of Period	190	225
Cash and Cash Equivalents at End of Period	2,000	278
Cash paid for interest	0	0
Cash paid for taxes	$ 0	$ 0

NOTE 1 - ORGANIZATION AND PRINC

NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES	9 Months Ended
	Sep. 30, 2023
Notes
NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES	NOTE 1 – ORGANIZATION AND PRINCIPAL ACTIVITIES HST Global, Inc. (the "Company") was incorporated on April 11, 1984 under the laws of the State of Delaware under the name of NT Holding Corporation. The Company has made several acquisitions and disposals of various business entities and activities. On May 9, 2008, the Company entered into a Merger and share exchange agreement with Health Source Technologies, Inc. This business acquisition was accounted for as a reverse merger or recapitalization of Health Source Technologies, Inc. At the time of the merger NT Holding Corporation had disposed of its assets and liabilities and had minimal operations. Immediately after the acquisition the Company changed its name to HST Global, Inc. Health Source Technologies, Inc. was incorporated under the laws of the State of Nevada on August 6, 2007. The Company is currently headquartered in Hampton, Virginia. The Company was founded as an Integrated Health and Wellness Biotechnology company with a plan to develop and /or acquire a network of Wellness Centers worldwide that would be primarily focused on the homeopathic and alternative treatment of late stage cancer. To date we have not been unable to initiate all of the elements of our original business plan. While we are continuing to seek opportunities to create new revenue streams based on our ongoing research in conjunction with potential partners by adding the Company’s access to new product developments that will allow the company to take advantage of opportunities to integrate assets, rights, and distribution channels to create potential revenue streams within the Company in relationships with other companies to attract the additional capital and personnel to meet our goals. The accompanying interim condensed financial statements have been prepared in accordance with the instructions to Form 10-Q pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”) and, therefore, do not include all information and footnotes necessary for a complete presentation of the Company’s financial position, results of operations, cash flows, and stockholders’ equity in conformity with generally accepted accounting principles. In the opinion of management, all adjustments considered necessary for a fair presentation of the results of operations and financial position have been included and all such adjustments are of a normal recurring nature. The unaudited quarterly condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Annual Report on Form 10-K of the Company as of and for the fiscal year ended December 31, 2022. The results of operations for the period ended September 30, 2023, are not necessarily indicative of the results for a full-year period.

NOTE 2 - SIGNIFICANT ACCOUNTING

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	9 Months Ended
	Sep. 30, 2023
Notes
NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES	NOTE 2 – SIGNIFICANT ACCOUNTING POLICIES Basis of Presentation The accompanying condensed financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the SEC to Form 10-K and 10-Q. Accounting Method The Company’s condensed financial statements are prepared using the accrual method of accounting. The Company has elected a December 31 year-end. Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates. Cash and Cash Equivalents We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. Basic and Diluted Income (Loss) Per Share The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260, “ Earnings Per Share Stock-Based Compensation The Company adopted ASC 718, “Stock Compensation” Fair Value of Financial Instruments The Company adopted ASC 820, “ Fair Value Measurement The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis. Recently Issued Accounting Pronouncements Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed financial statements.

NOTE 3 - GOING CONCERN

NOTE 3 - GOING CONCERN	9 Months Ended
	Sep. 30, 2023
Notes
NOTE 3 - GOING CONCERN	NOTE 3 – GOING CONCERN The Company’s condensed financial statements are prepared using U.S. GAAP applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course of business. The Company has not yet established an ongoing source of revenues sufficient to cover its operating costs and allow it to continue as a going concern for a period of one year from the issuance of these financial statements. The ability of the Company to continue as a going concern is dependent on the Company obtaining adequate capital to fund operating losses until it becomes profitable. If the Company is unable to obtain adequate capital, it could be forced to cease operations. These factors raise substantial doubt regarding the Company’s ability to continue as a going concern. Management’s plan to support the Company in its operations and to maintain its business strategy is to raise funds through public offerings and to rely on officers and directors to perform essential functions with minimal compensation. If the Company does not raise all of the funds it needs from public offerings, it will have to find alternative sources, such as a second public offering, a private placement of securities, or loans from its officers, directors or others. If the Company requires additional cash and is unable to raise it, it will either have to suspend operations until the cash is raised, or cease business entirely. The ability of the Company to continue as a going concern is dependent upon its ability to successfully accomplish the plans described in the preceding paragraph and eventually secure other sources of financing and attain profitable operations. The accompanying condensed financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

NOTE 4 - RELATED PARTY TRANSACT

NOTE 4 - RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2023
Notes
NOTE 4 - RELATED PARTY TRANSACTIONS	NOTE 4 – RELATED PARTY TRANSACTIONS Loans or Advances from Related Party During the nine months ended September 30, 2023, the Company received $17,243 in additional cash loans from Ronald R. Howell. As of September 30, 2023, the Company owed Mr. Howell $93,319 in notes payable. Executive Offices The Company’s executive offices are located at 150 Research Dr., Hampton VA. These offices are leased by The Health Network, Inc. (“THN”), of which Ron Howell is President. THN allows the Company to use the office space without a formal sublease or rental agreement. Consulting Agreements The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services through December 31, 2010. The Company had agreed to continue to

NOTE 5 - SUBSEQUENT EVENTS

NOTE 5 - SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2023
Notes
NOTE 5 - SUBSEQUENT EVENTS	NOTE 5 – SUBSEQUENT EVENTS In accordance with ASC 855, “Subsequent Events”

NOTE 2 - SIGNIFICANT ACCOUNTI_2

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2023
Policies
Basis of Presentation	Basis of Presentation The accompanying condensed financial statements and related notes include the activity of the Company and have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and with the rules and regulations of the SEC to Form 10-K and 10-Q.

NOTE 2 - SIGNIFICANT ACCOUNTI_3

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Accounting Method (Policies)	9 Months Ended
	Sep. 30, 2023
Policies
Accounting Method	Accounting Method The Company’s condensed financial statements are prepared using the accrual method of accounting. The Company has elected a December 31 year-end.

NOTE 2 - SIGNIFICANT ACCOUNTI_4

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Use of Estimates (Policies)	9 Months Ended
	Sep. 30, 2023
Policies
Use of Estimates	Use of Estimates The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, and the disclosure of contingent assets and liabilities at the date of the financial statements, and the reported amount of revenues and expenses during the reporting period. Actual results could differ from those estimates.

NOTE 2 - SIGNIFICANT ACCOUNTI_5

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Cash and Cash Equivalents (Policies)	9 Months Ended
	Sep. 30, 2023
Policies
Cash and Cash Equivalents	Cash and Cash Equivalents We maintain cash balances in non-interest-bearing accounts, which do not currently exceed federally insured limits. For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents.

NOTE 2 - SIGNIFICANT ACCOUNTI_6

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Basic and Diluted Income (Loss) Per Share (Policies)	9 Months Ended
	Sep. 30, 2023
Policies
Basic and Diluted Income (Loss) Per Share	Basic and Diluted Income (Loss) Per Share The computations of basic loss per share of common stock are based on the weighted average number of shares outstanding at the date of the financial statements. The Company computes net income (loss) per share in accordance with ASC 260, “ Earnings Per Share

NOTE 2 - SIGNIFICANT ACCOUNTI_7

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Stock-Based Compensation (Policies)	9 Months Ended
	Sep. 30, 2023
Policies
Stock-Based Compensation	Stock-Based Compensation The Company adopted ASC 718, “Stock Compensation”

NOTE 2 - SIGNIFICANT ACCOUNTI_8

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Fair Value of Financial Instruments (Policies)	9 Months Ended
	Sep. 30, 2023
Policies
Fair Value of Financial Instruments	Fair Value of Financial Instruments The Company adopted ASC 820, “ Fair Value Measurement The Company currently does not have non-financial assets or non-financial liabilities that are required to be measured at fair value on a recurring basis.

NOTE 2 - SIGNIFICANT ACCOUNTI_9

NOTE 2 - SIGNIFICANT ACCOUNTING POLICIES: Recently Issued Accounting Pronouncements (Policies)	9 Months Ended
	Sep. 30, 2023
Policies
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements Management has considered all recent accounting pronouncements issued since the last audit of our consolidated financial statements. The Company’s management believes that these recent pronouncements will not have a material effect on the Company’s unaudited condensed financial statements.

NOTE 4 - RELATED PARTY TRANSA_2

NOTE 4 - RELATED PARTY TRANSACTIONS (Details) - USD ($)	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Loans or advances from related party	$ 93,319	$ 76,076
Notes Payable - Related Parties
Related Party Transaction, Description of Transaction	During the nine months ended September 30, 2023, the Company received $17,243 in additional cash loans from Ronald R. Howell. As of September 30, 2023, the Company owed Mr. Howell $93,319 in notes payable.
Increase (Decrease) in Due to Related Parties	$ 17,243
Executive Offices
Related Party Transaction, Description of Transaction	THN allows the Company to use the office space without a formal sublease or rental agreement.
Howell Consulting Agreement
Related Party Transaction, Description of Transaction	The Company has entered into a consulting agreement with Mr. Howell, President of the Company, whereby the Company agreed to pay Mr. Howell $10,000 per month for consulting services
Loans or advances from related party	$ 452,275	$ 360,000